A growing number of cancer practices are sequencing the DNA of tumors to uncover their genetic abnormalities. The aim: to pair a drug with the specific mutation fueling a patient’s disease.
WSJ reporter Ron Winslow and I spoke with UC San Francisco's Dr. Trever Bivona about the latest developments and challenges in genetically-targeted cancer treatment.
I find the idea of personalized medicine based on genetics fascinating. I hope to do more stories on this subject matter soon.
WSJ reporter Ron Winslow and I spoke with UC San Francisco's Dr. Trever Bivona about the latest developments and challenges in genetically-targeted cancer treatment.
I find the idea of personalized medicine based on genetics fascinating. I hope to do more stories on this subject matter soon.
RSS Feed
